According to ORIC Pharmaceuticals
's latest financial reports the company has $0.26 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
|Year||Cash on Hand||Change|
|Company||Cash on Hand||differencediff.||Country|
|$0.26 B||0.00%||🇺🇸 USA|